Inflammatory phenotyping predicts clinical outcome in COVID-19

Hannah Burke(Southampton General Hospital), Christopher Kipps, Tristan Clark(Southampton General Hospital), C. Mirella Spalluto(University of Southampton), Michael Celinski, Anna Freeman(Southampton General Hospital), Natasha Sheard(University Hospital Southampton NHS Foundation Trust), Florina Borca(University Hospital Southampton NHS Foundation Trust), Gareth J. Thomas(University of Southampton), Stephen Poole(Southampton General Hospital), Tom Wilkinson(University Hospital Southampton NHS Foundation Trust), James Batchelor, Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Hang Phan(Children's Hospital 2), Nathan J. Brendish(Southampton General Hospital), Beth Stuart(Queen Mary University of London), Doriana Cellura(Southampton General Hospital), Sarah Williams(University Hospital Southampton NHS Foundation Trust), Karl J. Staples(University Hospital Southampton NHS Foundation Trust)
Respiratory Research
September 22, 2020
10.1186/s12931-020-01511-z
Cited by 99

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
|Intensive Care Medicine|2020|588